171 related articles for article (PubMed ID: 36147467)
1. SPC25 promotes proliferation and stemness of hepatocellular carcinoma cells via the DNA-PK/AKT/Notch1 signaling pathway.
Yang J; Huang Y; Song M; Pan Q; Zhao J; He J; Ouyang D; Yang C; Han Y; Tang Y; Wang Q; He J; Li Y; Chen H; Weng D; Xiang T; Xia J
Int J Biol Sci; 2022; 18(14):5241-5259. PubMed ID: 36147467
[TBL] [Abstract][Full Text] [Related]
2. SPC25 promotes hepatocellular carcinoma metastasis via activating the FAK/PI3K/AKT signaling pathway through ITGB4.
Shi WK; Shang QL; Zhao YF
Oncol Rep; 2022 May; 47(5):. PubMed ID: 35293598
[TBL] [Abstract][Full Text] [Related]
3. SPC25 overexpression promotes tumor proliferation and is prognostic of poor survival in hepatocellular carcinoma.
Zhang B; Zhou Q; Xie Q; Lin X; Miao W; Wei Z; Zheng T; Pang Z; Liu H; Chen X
Aging (Albany NY); 2020 Dec; 13(2):2803-2821. PubMed ID: 33408271
[TBL] [Abstract][Full Text] [Related]
4. Notch1 signaling sensitizes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human hepatocellular carcinoma cells by inhibiting Akt/Hdm2-mediated p53 degradation and up-regulating p53-dependent DR5 expression.
Wang C; Qi R; Li N; Wang Z; An H; Zhang Q; Yu Y; Cao X
J Biol Chem; 2009 Jun; 284(24):16183-16190. PubMed ID: 19376776
[TBL] [Abstract][Full Text] [Related]
5. SPC25 may promote proliferation and metastasis of hepatocellular carcinoma via p53.
Chen F; Zhang K; Huang Y; Luo F; Hu K; Cai Q
FEBS Open Bio; 2020 Jul; 10(7):1261-1275. PubMed ID: 32351050
[TBL] [Abstract][Full Text] [Related]
6. Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma.
Toh TB; Lim JJ; Hooi L; Rashid MBMA; Chow EK
J Hepatol; 2020 Jan; 72(1):104-118. PubMed ID: 31541681
[TBL] [Abstract][Full Text] [Related]
7. As a downstream target of the AKT pathway, NPTX1 inhibits proliferation and promotes apoptosis in hepatocellular carcinoma.
Zhao Y; Yu Y; Zhao W; You S; Feng M; Xie C; Chi X; Zhang Y; Wang X
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31113871
[TBL] [Abstract][Full Text] [Related]
8. ABL1, Overexpressed in Hepatocellular Carcinomas, Regulates Expression of NOTCH1 and Promotes Development of Liver Tumors in Mice.
Wang F; Hou W; Chitsike L; Xu Y; Bettler C; Perera A; Bank T; Cotler SJ; Dhanarajan A; Denning MF; Ding X; Breslin P; Qiang W; Li J; Koleske AJ; Qiu W
Gastroenterology; 2020 Jul; 159(1):289-305.e16. PubMed ID: 32171747
[TBL] [Abstract][Full Text] [Related]
9. Carboxypeptidase A6 Promotes the Proliferation and Migration of Hepatocellular Carcinoma by Up-regulating AKT Signaling Pathway.
Huang QB; Zhang HW; Liao ZB
Curr Med Sci; 2019 Oct; 39(5):727-733. PubMed ID: 31612389
[TBL] [Abstract][Full Text] [Related]
10. Targeting TROY-mediated P85a/AKT/TBX3 signaling attenuates tumor stemness and elevates treatment response in hepatocellular carcinoma.
Liu B; Fang X; Kwong DL; Zhang Y; Verhoeft K; Gong L; Zhang B; Chen J; Yu Q; Luo J; Tang Y; Huang T; Ling F; Fu L; Yan Q; Guan XY
J Exp Clin Cancer Res; 2022 May; 41(1):182. PubMed ID: 35610614
[TBL] [Abstract][Full Text] [Related]
11. SPAG5 interacts with CEP55 and exerts oncogenic activities via PI3K/AKT pathway in hepatocellular carcinoma.
Yang YF; Zhang MF; Tian QH; Fu J; Yang X; Zhang CZ; Yang H
Mol Cancer; 2018 Aug; 17(1):117. PubMed ID: 30089483
[TBL] [Abstract][Full Text] [Related]
12. Activated Notch signaling augments cell growth in hepatocellular carcinoma via up-regulating the nuclear receptor NR4A2.
Zhu B; Sun L; Luo W; Li M; Coy DH; Yu L; Yu W
Oncotarget; 2017 Apr; 8(14):23289-23302. PubMed ID: 28423575
[TBL] [Abstract][Full Text] [Related]
13. Integrin alpha 7 correlates with poor clinical outcomes, and it regulates cell proliferation, apoptosis and stemness via PTK2-PI3K-Akt signaling pathway in hepatocellular carcinoma.
Ge JC; Wang YX; Chen ZB; Chen DF
Cell Signal; 2020 Feb; 66():109465. PubMed ID: 31698037
[TBL] [Abstract][Full Text] [Related]
14. APLN promotes hepatocellular carcinoma through activating PI3K/Akt pathway and is a druggable target.
Chen H; Wong CC; Liu D; Go MYY; Wu B; Peng S; Kuang M; Wong N; Yu J
Theranostics; 2019; 9(18):5246-5260. PubMed ID: 31410213
[No Abstract] [Full Text] [Related]
15. LINC02154 promotes the proliferation and metastasis of hepatocellular carcinoma by enhancing SPC24 promoter activity and activating the PI3K-AKT signaling pathway.
Yue H; Wu K; Liu K; Gou L; Huang A; Tang H
Cell Oncol (Dordr); 2022 Jun; 45(3):447-462. PubMed ID: 35543858
[TBL] [Abstract][Full Text] [Related]
16. Musashi2 contributes to the maintenance of CD44v6+ liver cancer stem cells via notch1 signaling pathway.
Wang X; Wang R; Bai S; Xiong S; Li Y; Liu M; Zhao Z; Wang Y; Zhao Y; Chen W; Billiar TR; Cheng B
J Exp Clin Cancer Res; 2019 Dec; 38(1):505. PubMed ID: 31888685
[TBL] [Abstract][Full Text] [Related]
17. The stromal-tumor amplifying STC1-Notch1 feedforward signal promotes the stemness of hepatocellular carcinoma.
Bai S; Zhao Y; Chen W; Peng W; Wang Y; Xiong S; Aruna ; Li Y; Yang Y; Chen S; Cheng B; Wang R
J Transl Med; 2023 Mar; 21(1):236. PubMed ID: 37004088
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-1468 promotes tumor progression by activating PPAR-γ-mediated AKT signaling in human hepatocellular carcinoma.
Liu Z; Wang Y; Dou C; Sun L; Li Q; Wang L; Xu Q; Yang W; Liu Q; Tu K
J Exp Clin Cancer Res; 2018 Mar; 37(1):49. PubMed ID: 29510736
[TBL] [Abstract][Full Text] [Related]
19. Simvastatin induces growth inhibition and apoptosis in HepG2 and Huh7 hepatocellular carcinoma cells via upregulation of Notch1 expression.
Huang X; Ma J; Xu J; Su Q; Zhao J
Mol Med Rep; 2015 Mar; 11(3):2334-40. PubMed ID: 25412322
[TBL] [Abstract][Full Text] [Related]
20. Formiminotransferase Cyclodeaminase Suppresses Hepatocellular Carcinoma by Modulating Cell Apoptosis, DNA Damage, and Phosphatidylinositol 3-Kinases (PI3K)/Akt Signaling Pathway.
Chen J; Chen Z; Huang Z; Yu H; Li Y; Huang W
Med Sci Monit; 2019 Jun; 25():4474-4484. PubMed ID: 31203308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
